Advertisement

Sports Medicine

, Volume 27, Issue 1, pp 11–21 | Cite as

Attention Deficit Hyperactivity Disorder, CNS Stimulants and Sport

  • Greg Hickey
  • Peter Fricker
Review Article

Abstract

Attention deficit hyperactivity disorder (ADHD) affects 1 to 10% of children and is characterised by a persistent pattern of inattention and/or hyperactivity/ impulsivity. Over one-half of children with ADHD have associated conditions, including learning disabilities, conduct disorders, poor coordination, depression, anxiety, obsessive-compulsive disorders and bipolar disorders.

CNS stimulant medication used in the management of ADHD is not permitted for use in competition by the International Olympic Committee (IOC) and this poses a problem for the physicians of patients with ADHD. On the one hand, attention and concentration are improved by stimulant medication and fine motor coordination and balance are improved after methylphenidate administration, but these therapeutic and sport-related benefits are not available to the athlete with ADHD who wishes to compete under IOC rules. It has been suggested that treatment with methylphenidate may be suitable for athletes with ADHD, as cessation of therapy 24 hours before competition is usually adequate to allow drug clearance which should avoid a positive result being returned on drug testing.

More research is needed to establish whether stimulant medication for athletes with ADHD provides an unfair advantage in competition.

Keywords

Attention Deficit Hyperactivity Disorder Adis International Limited Methylphenidate Attention Deficit Hyperactivity Disorder Stimulant Medication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994Google Scholar
  2. 2.
    Green C. Attention deficit hyperactivity disorder – clearing the confusion. Mod Med (Aust) 1998; 41 (3): 118–26Google Scholar
  3. 3.
    Jarman FC. Current approaches to management of attention deficit hyperactivity disorder. Aust Educ Dev Psych 1996; 13 (1): 46–55Google Scholar
  4. 4.
    Jarman FC. Management of hyperactivity. Curr Ther 1992; 33 (8): 31–9Google Scholar
  5. 5.
    Hazell P. Stimulant treatment for attention deficit hyperactivity disorder. Aust Prescriber 1995; 18 (3): 60–63Google Scholar
  6. 6.
    Safer DJ, Karger JM. A survey of medication treatment for hyperactive/inattentive students. JAMA 1988; 260: 2256–8CrossRefGoogle Scholar
  7. 7.
    Barkley RA. The north american perspective on attention deficit hyperactivity disorder. Aust Educ Dev Psych 1996; 13 (1): 2–23Google Scholar
  8. 8.
    Harvey WJ, Reid G. Motor performance of children with attention- deficit hyperactivity disorder: a preliminary investigation. Adapt Phys Activ Q 1997; 14: 189–202Google Scholar
  9. 9.
    Wade MG. Effects of methylphenidate on motor skills acquisition of hyperactive children. J Learn Disabil 1976; 9 (7): 48–52CrossRefGoogle Scholar
  10. 10.
    Luk Si, Leung PWI, Yuen J. Clinic observations in the assessment of pervasiveness of childhood hyperactivity. J Child Psychol Psychiatry 1991; 32: 833–50CrossRefGoogle Scholar
  11. 11.
    Moffitt TE. Juvenile delinquency and attention deficit disorder: boys developmental trajectories from age 3 to age 15. Child Dev 1990; 61: 893–910Google Scholar
  12. 12.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., revised. Washington, DC: American Psychiatric Association, 1987Google Scholar
  13. 13.
    Murphy MA, Hagerman RJ. Attention deficit hyperactivity disorder in children: diagnosis, treatment and follow-up. J Pediatr Health Care 1992; 6: 2–11PubMedCrossRefGoogle Scholar
  14. 14.
    Satterfield JH, Satterfield BT, Schell AM. Therapeutic interventions to prevent delinquency in hyperactive boys. J Am Acad Child Adolesc Psychiatry 1987; 26: 56–64PubMedCrossRefGoogle Scholar
  15. 15.
    Anastopoulos AD, Du Paul GJ, Barkley RA. Stimulant medication and parent training therapies for attention deficit hyperactivity disorder. J Learn Disabil 1991; 24: 210–8PubMedCrossRefGoogle Scholar
  16. 16.
    Jacobovitz D, Sroufe LA, Stewart M, et al. Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry 1990; 29: 677–88CrossRefGoogle Scholar
  17. 17.
    Ahmann PA, Waltonen SJ, Olson KA, et al. Placebo-controlled evaluation of ritalin side effects. Pediatrics 1993; 91: 1101–6PubMedGoogle Scholar
  18. 18.
    Drug evaluation monograph on methylphenidate. Melbourne: Drug Information Centre, Royal Children’s Hospital, 1995Google Scholar
  19. 19.
    Drug evaluation monograph on dextroamphetamine. Melbourne: Drug Information Centre, Royal Children’s Hospital, 1995Google Scholar
  20. 20.
    Levy F. Side effects of stimulant use. J Paediatr Child Health 1993; 29: 250–4PubMedCrossRefGoogle Scholar
  21. 21.
    Safer DJ. Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder. J Child Adolesc Psychopharm 1992; 2 (4): 279–90CrossRefGoogle Scholar
  22. 22.
    Jarman FC. Attention deficit hyperactivity disorder. Aust Paediatr Rev 1995; 5 (1): 1–3Google Scholar
  23. 23.
    Knights RM, Hinton GG. The effects of methylphenidate (ritalin) on the motor skills and behaviour of children with learning problems. J Nerv Ment Dis 1969; 148 (6): 643–53PubMedCrossRefGoogle Scholar
  24. 24.
    de Sonneville LMJ, Njiokiktjien C, Hilhorst RC. Methylphenidateinduced changes in ADHD information processors. J Child Psychol Psychiatr 1991; 32 (2): 285–95CrossRefGoogle Scholar
  25. 25.
    Tannock R, Schachar RJ, Carr RP, et al. Dose-response effects of methylphenidate on academic performance and overt behaviour in hyperactive children. Pediatrics 1989; 84 (4): 648–57PubMedGoogle Scholar
  26. 26.
    Funk JB, Chessare JB, Weaver MT, et al. Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate. Pediatrics 1993; 91 (4): 816–9PubMedGoogle Scholar
  27. 27.
    Pelham WE, McBurnett K, Harper GW, et al. Methylphenidate and baseball playing in ADHD children: whos on first? J Consult Clin Psychol 1990; 58 (1): 130–3PubMedCrossRefGoogle Scholar
  28. 28.
    Chandler JV, Blair SN. The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc 1980; 12 (1): 65–9PubMedGoogle Scholar
  29. 29.
    Krusch DA, Klorman R, Brumaghim JT, et al. Methylphenidate slows reactions of children with attention deficit disorder during and after an error. J Abnorm Child Psychol 1996; 24 (5): 633–50PubMedCrossRefGoogle Scholar
  30. 30.
    Bishop P, Beyer R. Attention deficit hyperactivity disorder (ADHD): implications for physical educators. Palaestra 1995; VII (4), 39–46Google Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Greg Hickey
    • 1
  • Peter Fricker
    • 1
  1. 1.Australian Institute of SportCanberraAustralia

Personalised recommendations